Abstract
Porous silicon (pSi) nanomaterials are increasingly attractive for biomedical applications due to their promising properties such as simple and feasible fabrication procedures, tunable morphology, versatile surface modification routes, biocompatibility and biodegradability. This review focuses on recent advances in surface modification of pSi for controlled drug delivery applications. A range of functionalization strategies and fabrication methods for pSi-polymer hybrids are summarized. Surface engineering solutions such as stimuli-responsive polymer grafting, stealth coatings and active targeting modifications are highlighted as examples to demonstrate what can be achieved. Finally, the current status of engineered pSi nanomaterials for in vivo applications is reviewed and future prospects and challenges in drug-delivery applications are discussed.
Original language | English |
---|---|
Pages (from-to) | 3213-3230 |
Number of pages | 18 |
Journal | Nanomedicine |
Volume | 14 |
Issue number | 24 |
DOIs | |
Publication status | Published - Dec 2019 |
Keywords
- active targeting
- drug delivery
- in vivo application
- porous silicon
- pSi-polymer hybrids
- stealth coating
- stimuli-responsive
- surface modification
Equipment
-
Melbourne Centre for Nanofabrication
Sean Langelier (Manager)
Office of the Vice-Provost (Research and Research Infrastructure)Facility/equipment: Facility